About Us

QPRN vision

The vision of the QPRN since 2001 is to be a leader in representing a wide range of research stakeholders in the search to understand the cellular and molecular basis of pain, to improve our assessment and treatment (pharmacological and non-pharmacological) of pain, to improve prevention efforts, as well as to ensure efficient and effective knowledge translation to adopt best practices in the multiple sectors of our healthcare system.

research network

We aim at achieving our goals through cohesive efforts between a group of 90 researchers associated to the four University Health Networks (Réseaux universitaires intégrés de santé; RUIS) of the province of Quebec: Université Laval, McGill University, Université de Montréal and Université de Sherbrooke, and to the Université du Québec network, Concordia University, Bishop University and TELUQ.
The network also benefits from collaborations with partners of choice as well as clinical experts.

Funding of the QPRN

The Fonds de recherche du Québec – Santé (FRQS) allow to :

• Financially support the Pain Network
• Stimulate cutting edge research on chronic pain
• Perfect the public and health care professional’s education on chronic pain
• Improve our background knowledge on persistent pain
• Contribute to enhancing physicians judgement for diagnosing and treating persistent pain

Committees

QPRN Management committee

QPRN direction committee

The Management Committee of the network is composed of :

• Management Committee

• A representative of the Quebec Chronic Pain Association (AQDC)

Vincent Raymond

• A representative of the Quebec Network of Junior Pain Investigators (QNJPI)

Marimée Godbout-Parent
Monica Sean

• A representative from each university

Philippe Sarret (Université de Sherbrooke)
Pierre Rainville (Université de Montréal)
Gilles Lavigne (CR-CHUM)
Yves de Koninck (Université Laval)
Reza Sharif Naeini (McGill University)

QPRN scientific committee

The Scientific Committee of the network is composed of :

• The Management Committee

• The directors of the Strategic Initiatives

Strategic initiative on mapping of pain circuits : Reza Sharif (McGill University)
Strategic initiative on adverse effects of pain medication : Mélanie Bérubé (Université Laval)
Strategic initiative on low back pain risk factors : Jean-Sébastien Roy (Université Laval) / Hugo Massé-Alarie (Université Laval) / Carol Meloto (McGill University)
Strategic initiative on knowledge transfer in pain research : Anne Marie Pinard (Université Laval)
Strategic initiative on judicious use of opioids : Gabrielle Pagé (Université de Montréal) et Marc Martel (McGill University)

• The directors of the Technical Platforms

Technical platform on molecular tools and cellular imaging : Yves de Koninck (Université Laval)
Technical platform on preclinical systems monitoring : Jeffrey Mogil (McGill University)
Technical platform on brain imaging : Pierre Rainville (Université de Montréal) and Mathieu Roy (McGill University)
Technical platform on genetics and genomics analysis : Luda Diatchenko (McGill University)
Technical platform on patient oriented research : Manon Choinière (Université de Montréal)